BioSpace News Archive

Job Trends

Entrepix Medical Announces the Launch of Transformational Surgical Blade Technology Focused on Patient HealingPlanatome® Redefines Surgical Expectations Putting Extraordinary Patented Technology in Exceptional Surgical Hands

Entrepix Medical, LLC, a medical technology startup focused on applying advanced nano-polishing technology used in microchip manufacturing to surgical devices, today announced the launch of Planatome® Technology.

October 1, 2020
·
4 min read
BioMidwest

Michigan Advanced Psychiatry Opens New Facility To Offer Deep Transcranial Magnetic Stimulation (Deep TMS) for Patients With Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

FDA-cleared helmet approved to treat MDD and OCD is now available in Ann Arbor and surrounding areas

October 1, 2020
·
2 min read
ATW Tech announces a private placement of common shares valued at 1.5 million CAD and a letter of intent for the concurrent acquisition of Semeon Analytics Inc., an Artificial Intelligence company

ATW Tech Inc. (the “Company” or “ATWTech”) (TSX-V: ATW) is pleased to announce the signing of a letter of intent for a $1,500,000 private placement through the issuance of 30,000,000 common shares of the Company (the “Shares”) at a price of $0.05 per Share (the “Private Placement”).

October 1, 2020
·
9 min read
Business

Akari Therapeutics Announces Successful Scientific Advice Meeting with the European Medicines Agency (EMA) Establishing a Clear Path in Both U.S. and Europe for a Pivotal Phase III Study of Nomacopan for Treatment of Bullous Pemphigoid

The EMA and the FDA have both agreed to a Phase III randomized placebo-controlled study with nomacopan in moderate to severe bullous pemphigoid (BP) patients with a primary endpoint of disease remission on minimal oral corticosteroids (OCS) Nomacopan has been granted orphan drug designation by the EMA and the FDA for the treatment of BP Nomacopan, with its dual inhibition of complement (C5) and leukotriene (LTB4) together with downstream cytokines, is a novel treatment for BP that has the

October 1, 2020
·
7 min read
Discovery Life Sciences Launches SpecimenSeq™: Genomically and Clinically Annotated Biospecimen Sets to Speed Liquid Biopsy and Immunotherapy Development

Discovery Life Sciences™ (Discovery) announces the launch of a powerful new tool for liquid biopsy diagnostic assay and oncology drug developers: SpecimenSeq™

October 1, 2020
·
2 min read
Business

On Target Laboratories Announces the Appointment of Patrick Spangler as Chief Financial Officer

On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent markers to target and illuminate cancer during surgery, today announced that Patrick Spangler has joined the Company as Chief Financial Officer.

October 1, 2020
·
2 min read
Business

David Yurman Announces Annual Partnership With The Breast Cancer Research Foundation

- American luxury jeweler David Yurman announces its twelfth annual partnership with the Breast Cancer Research Foundation (BCRF), in support of Breast Cancer Awareness Month in October. David Yurman has p

October 1, 2020
·
2 min read
Deals

Tend Raises $37M Series B Led By GV

The technology-driven dental startup will use the funding to expand its footprint and launch new product offerings in 2021

October 1, 2020
·
3 min read
Business

Qualigen Therapeutics Expands Research Agreement with University of Louisville for ALAN Cancer Drug Candidate

Qualigen Therapeutics, Inc. (NASDAQ: QLGN) announces it has entered into an amended Sponsored Research Agreement with the University of Louis

October 1, 2020
·
6 min read
Biotech Beach

Agendia Celebrates Breast Cancer Awareness Month with Digital Art Installation

In celebration of Breast Cancer Awareness Month, Agendia, Inc ., a world leader in precision oncology for breast cancer, is proud to present the I AM HERE campaign, a collection of illustrations and stories that capture the incredibly personal journey of a breast canc

October 1, 2020
·
3 min read